دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN Free
doi : 10.1093/ibd/izae067
Dexamethasone Upregulates the Expression of the Human SLC26A3 (DRA, Down-Regulated in Adenoma) Transporter (an IBD Susceptibility Gene) in Intestinal Epithelial Cells and Attenuates Gut Inflammation
doi : 10.1093/ibd/izae271
Pan-enteric Capsule Endoscopy to Characterize Crohn’s Disease Phenotypes and Predict Clinical Outcomes in Children and Adults: The Bomiro Study Free
doi : 10.1093/ibd/izae052
Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device Free
doi : 10.1093/ibd/izae054
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN
doi : 10.1093/ibd/izae094
Accurate, Robust, and Scalable Machine Abstraction of Mayo Endoscopic Subscores From Colonoscopy Reports Free
doi : 10.1093/ibd/izae068
Allogenic Stem Cells in Anal Fistulas of Crohn’s Disease: From Promising Premises to Real Life Experience
doi : 10.1093/ibd/izae065
Prospective Evaluation of the Prediction Score for a Mild Course of Crohn’s Disease (PreMiCC) in Newly Diagnosed Patients With Crohn’s Disease: The PROGNOS Study Open Access
doi : 10.1093/ibd/izae086
Postoperative Crohn’s Disease Recurrence Risk and Optimal Biologic Timing After Temporary Diversion Following Ileocolic Resection
doi : 10.1093/ibd/izae117
Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity Free
doi : 10.1093/ibd/izae090
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn’s Disease Open Access
doi : 10.1093/ibd/izae089
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial Open Access
doi : 10.1093/ibd/izae088
Pharmacologic Anticoagulation Is Associated With a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients With a Prior Thrombosis Free
doi : 10.1093/ibd/izae100
Inflammation-related Proteins Support Diagnosis of Inflammatory Bowel Disease and Are Modified by Exclusive Enteral Nutrition in Children With Crohn’s Disease, Especially of Ileal Phenotype Open Access
doi : 10.1093/ibd/izae107
Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience Free
doi : 10.1093/ibd/izad311
Circulating Extracellular Matrix Products as Indicators of Disease Burden and Predictors of Disease Course in Ulcerative Colitis
doi : 10.1093/ibd/izae244
Why Symptoms Linger in Quiescent Crohn’s Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways
doi : 10.1093/ibd/izae238
Anti-integrin αvβ6 Antibodies Predict Pouchitis in Patients With Ulcerative Colitis After Restorative Proctocolectomy With Ileal Pouch-Anal Anastomosis Open Access
doi : 10.1093/ibd/izae263
MIP4IBD: An Easy and Rapid Genotyping-by-Sequencing Assay for the Inflammatory Bowel Diseases Risk Loci
doi : 10.1093/ibd/izae289
Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn’s Disease Open Access
doi : 10.1093/ibd/izae262
Diagnosis of Inflammatory Bowel Disease–Associated Peripheral Arthritis: A Systematic Review
doi : 10.1093/ibd/izae114
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials Open Access
doi : 10.1093/ibd/izae131
Unraveling Twisted Pouch Syndrome: A Narrative Review of Classification, Diagnosis, Treatment, and Prevention
doi : 10.1093/ibd/izae161
Mucosal and Transmural Healing and Long-term Outcomes in Crohn’s Disease Open Access
doi : 10.1093/ibd/izae159
Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch
doi : 10.1093/ibd/izae164
Diagnostic and Therapeutic Challenges in Severe Peristomal Pyoderma Gangrenosum Open Access
doi : 10.1093/ibd/izae167
Challenges in the Management of Acute Severe Ulcerative Colitis in a Patient With Guillain-Barré Syndrome Associated With Infliximab
doi : 10.1093/ibd/izae235
Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Call to Action to Improve Patient Care
doi : 10.1093/ibd/izae277
Unmasking the Steroid Curtain: Reevaluating Corticosteroid Use in IBD Clinical Trials
doi : /10.1093/ibd/izae245
Comment on: “The Burden of Psychiatric Manifestations in Inflammatory Bowel Diseases: A Systematic Review With Meta-analysis
doi : 10.1093/ibd/izae260
